Full Press Release Details
argenx Highlights Strategic Priorities for 2022.
ARGX
argenx Highlights Strategic Priorities for 2022
Key Takeaway: argenx Highlights Strategic Priorities for 2022
Price reaction · baseline $337.57 (2022-01-05 close) · hit after-hours · 2 other ARGX headline(s) in the window, move may be shared
day 0 close · peak
-1.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis